Based on the clinicopathological impact of CD44 in breast cancer basal type, it is applied as a molecular diagnostic marker, prognostic tool, therapeutic target, targeting ligand-receptor in various stages of clinical development. The gene discussed is CD44; the disease is breast cancer.